Seaport Therapeutics Inc (SPTX) Price Prediction & ForecastSPTXSeaport Therapeutics Inc

Alphio's SPTX stock price prediction model matches the current Seaport Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $17.87 (+0.22%). The 1-week path is $18.24 (+2.32%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Seaport Therapeutics, Inc. (SPTX) is a good buy right now due to its strong analyst ratings and promising clinical trial results. The stock is currently priced at $17.83, with a forward P/E ratio of 0, indicating no earnings expectations, which can be favorable for growth potential. Analysts have set a price target averaging $37.13, suggesting a substantial upside of 72.61%. The recent positive Phase 1 results for GlyphAllo further enhance its growth prospects, although the company reported a significant net loss of $62.6 million in Q2 2026, which remains a key risk.

Seaport Therapeutics Inc (SPTX) last closed at $17.83, gaining +1.31%. These facts feed the 1-day and 1-week SPTX price prediction above.